NCT00019630 2024-03-04Liposomal Doxorubicin in Treating Children With Refractory Solid TumorsNational Cancer Institute (NCI)Phase 1 Completed
NCT04430842 2023-01-18Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072SQuadriga Biosciences, Inc.Phase 1 Completed15 enrolled
NCT03245788 2019-04-08Effectiveness of Lay Navigators in Meeting Cancer Patients' Non-Clinical Needs: A Pilot StudyStanford UniversityPhase NA Completed1,053 enrolled